Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$14.1B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$1.34B |
| 3 |
Visa
V
|
+$714M |
| 4 |
VanEck Semiconductor ETF
SMH
|
+$638M |
| 5 |
HONA
Honeywell Aerospace
HONA
|
+$508M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$4.58B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$1.74B |
| 3 |
Apple
AAPL
|
+$1.66B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.3B |
| 5 |
Amazon
AMZN
|
+$1.23B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.34% |
| 2 | Technology | 17.88% |
| 3 | Financials | 5.92% |
| 4 | Consumer Discretionary | 4.3% |
| 5 | Communication Services | 3.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LENZ
3476
LENZ Therapeutics
LENZ
$123M
| $285K | ﹤0.01% |
50,105
-101,282
| -67% | -$816K |
|
3477
Magnachip Semiconductor
MX
$120M
| $284K | ﹤0.01% |
60,000
+54,218
| +938% | +$263K |
|
3478
Willis Lease Finance
WLFC
$1.15B
| $283K | ﹤0.01% |
3,717
+2,154
| +138% | +$141K |
|
3479
Hamilton Insurance Group
HG
$3.28B
| $283K | ﹤0.01% |
8,347
+426
| +5% | +$13.4K |
|
3480
Forrester Research
FORR
$217M
| $283K | ﹤0.01% |
33,648
-1,593
| -5% | -$10.4K |
|
|
AVEX
3481
AEVEX Corp
AVEX
$1.11B
| $282K | ﹤0.01% |
+13,485
| New | +$350K |
|
3482
Coherus Oncology
CHRS
$175M
| $282K | ﹤0.01% |
201,143
+5,670
| +3% | +$9.26K |
|
3483
Greenlight Captial
GLRE
$486M
| $282K | ﹤0.01% |
17,399
+4,479
| +35% | +$77K |
|
3484
Orthofix Medical
OFIX
$385M
| $281K | ﹤0.01% |
30,760
-5,227
| -15% | -$57.6K |
|
3485
Simulations Plus
SLP
$373M
| $281K | ﹤0.01% |
15,334
+5,499
| +56% | +$84.5K |
|
|
BLDP
3486
Ballard Power Systems
BLDP
$748M
| $280K | ﹤0.01% |
72,099
+71,922
| +40,634% | +$293K |
|
3487
Olema Pharmaceuticals
OLMA
$766M
| $280K | ﹤0.01% |
22,366
+8,368
| +60% | +$112K |
|
3488
Clearwater Paper
CLW
$328M
| $279K | ﹤0.01% |
17,785
-6,118
| -26% | -$92.2K |
|
|
PXED
3489
Phoenix Education Partners
PXED
$932M
| $278K | ﹤0.01% |
8,477
-2,087
| -20% | -$62.4K |
|
3490
Nathan's Famous
NATH
$416M
| $278K | ﹤0.01% |
2,734
-695
| -20% | -$70.3K |
|
|
SLI
3491
Standard Lithium
SLI
$459M
| $277K | ﹤0.01% |
100,710
-338
| -0.3% | -$1.23K |
|
|
BLSH
3492
Bullish
BLSH
$5.7B
| $275K | ﹤0.01% |
11,736
+9,558
| +439% | +$332K |
|
3493
Inogen
INGN
$142M
| $275K | ﹤0.01% |
42,607
-480
| -1% | -$3.18K |
|
|
DMRA
3494
Damora Therapeutics
DMRA
$1.28B
| $274K | ﹤0.01% |
10,525
-11,509
| -52% | -$279K |
|
3495
NewAmsterdam Pharma
NAMS
$2.7B
| $274K | ﹤0.01% |
8,072
-13,708
| -63% | -$452K |
|
3496
iShares US Medical Devices ETF
IHI
$3.52B
| $272K | ﹤0.01% |
5,513
-96,432
| -95% | -$4.9M |
|
|
AIFC
3497
AI Financial Corp
AIFC
$72.4M
| $272K | ﹤0.01% |
465,153
-142,151
| -23% | -$119K |
|
3498
Columbus McKinnon
CMCO
$486M
| $272K | ﹤0.01% |
17,980
-2,799
| -13% | -$41.7K |
|
3499
Enanta Pharmaceuticals
ENTA
$346M
| $272K | ﹤0.01% |
18,655
+261
| +1% | +$3.51K |
|
|
BRUN
3500
PUT
Boost Run Inc
BRUN
$1.33B
| $272K | ﹤0.01% |
+7,000
| New | +$217K |
|
Similar funds
Barclays's Q2 2026 Portfolio in Review
As of Q2 2026, Barclays held 5,723 positions worth $521B, up 25% from $416B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays's Q2 2026 filing shows 722 new, 1,729 increased, 2,511 reduced and 392 closed positions. Its largest new stake was Honeywell Aerospace: 2,302,561 shares worth $509M. The largest sale was NVIDIA, an estimated $4.58B.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 46% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2026 buy was Honeywell Aerospace: 2,302,561 shares worth $509M.
- Barclays added most to iShares MSCI Emerging Markets ETF in Q2 2026, an estimated $14.1B increase.
- Barclays's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $4.58B.
- Barclays fully exited Masimo in Q2 2026, selling an estimated $488M.
- Barclays's ten largest holdings make up 43% of its $521B portfolio in Q2 2026.
- Barclays opened 722 new positions and closed 392 in Q2 2026.
- Barclays's portfolio value rose 25% quarter-over-quarter to $521B.
Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.